These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 12632426)
1. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426 [TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Dendrinos S; Sakkas E; Makrakis E Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178 [TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498 [TBL] [Abstract][Full Text] [Related]
4. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies. Goel N; Tuli A; Choudhry R Med Sci Monit; 2006 Mar; 12(3):CR132-6. PubMed ID: 16501426 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. Piette JC; Lê Thi Huong D; Wechsler B Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S51-4. PubMed ID: 10896991 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study. Heilmann L; Schorch M; Hahn T; Adasz G; Schilberz K; Adiguzel C; Fareed J Semin Thromb Hemost; 2008 Nov; 34(8):794-802. PubMed ID: 19214917 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies, infertility and recurrent miscarriage. Rai R; Regan L Curr Opin Obstet Gynecol; 1997 Aug; 9(4):279-82. PubMed ID: 9263721 [TBL] [Abstract][Full Text] [Related]
8. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355 [TBL] [Abstract][Full Text] [Related]
9. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Mak A; Cheung MW; Cheak AA; Ho RC Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971 [TBL] [Abstract][Full Text] [Related]
10. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin. Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397 [TBL] [Abstract][Full Text] [Related]
11. Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies. Katano K; Aoki K; Ogasawara M; Aoyama T; Suzumori K Acta Obstet Gynecol Scand; 1998 Mar; 77(3):354-6. PubMed ID: 9539288 [No Abstract] [Full Text] [Related]
12. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin. Prakash A; Laird S; Li TC; Ledger WL Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749 [TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study. Naru T; Khan RS; Ali R East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446 [TBL] [Abstract][Full Text] [Related]
14. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Hoppe B; Burmester GR; Dörner T Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome. Fouda UM; Sayed AM; Ramadan DI; Fouda IM J Obstet Gynaecol; 2010; 30(8):842-6. PubMed ID: 21126127 [TBL] [Abstract][Full Text] [Related]
16. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674 [TBL] [Abstract][Full Text] [Related]
17. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572 [TBL] [Abstract][Full Text] [Related]
18. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264 [TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome]. Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420 [TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Rai R; Cohen H; Dave M; Regan L BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]